Latest filing published 13 May 2020 for BIOTELEMETRY, INC., €789. Read the official filing
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert J. Rubin is a declared insider at 2 companies; the most frequent names are Biotelemetry, Inc. and Soligenix, Inc. Between 4 May 2016 and 11 May 2020, the trades on record add up to 13 filings.
On the open market, the record shows 1 purchase worth €9,599 and 3 sales worth €1.0M. The net balance comes to €1.0M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 6 share grants and 3 option exercises.
On 13 May 2020 came the latest disclosure, a share grant for €789 in Biotelemetry, Inc. The most recent open-market purchase was published on 20 December 2016, 3,592 days ago. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations